NVIDIA expands Microsoft partnership with Blackwell GPUs for AI infrastructure
Director Howard T. Slayen of AEHR Test Systems NASDAQ:AEHR, sold 6,000 shares of common stock on November 5, 2025, for approximately $154,357. This transaction comes as AEHR shares trade at $25.73, up 54.7% year-to-date and 112.5% over the past year, according to InvestingPro data.
The shares were sold at a weighted average price of $25.7262, with individual transactions occurring in a price range from $25.50 to $25.99. Following the transaction, Slayen directly owns 218,328 shares of AEHR Test Systems, which includes unvested restricted stock units. With a market capitalization of $773.6 million, AEHR appears overvalued compared to its InvestingPro Fair Value assessment, despite trading well below its 52-week high of $34.35.
The sale was executed on November 5, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The filing was signed by Chris Siu, Attorney-in-Fact. Investors seeking deeper insights into AEHR’s financial health (rated as "WEAK" by InvestingPro), valuation metrics, and future prospects can access the comprehensive Pro Research Report, available for AEHR and 1,400+ other US equities.
In other recent news, Aehr Test Systems reported its Q1 fiscal 2026 earnings, surpassing earnings per share (EPS) expectations with a significant surprise of 203.03%. The company posted an EPS of $0.01, outperforming the forecasted $0.0033. However, revenue did not meet projections, totaling $10.97 million compared to the anticipated $11.48 million. Additionally, Aehr Test Systems announced a strategic partnership with ISE Labs to enhance wafer-level test and burn-in services for high-performance computing and artificial intelligence applications. This collaboration aims to improve semiconductor defect detection early in production, which is crucial for maximizing yields and controlling costs. In another development, Craig-Hallum downgraded Aehr Test Systems from Buy to Hold, with a price target of $24.00. The research firm noted that the company’s near-term business dynamics remain unchanged, with growth expectations for fiscal year 2026 still focused on the latter half. Aehr Test Systems anticipates expansion across markets such as AI, silicon photonics, and gallium nitride.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.